Reaction vessel
Clean collection vials
Labelled storage vials
Dispensing tips
Magnetic stir bar
Amber vial if light-sensitive components are used
Low-protein-binding tubes for antibody handling
NSL Modules Used
Sterilization UV
Reservoir Dispense
Stirrer
Wait
Heater, optional and only under mild antibody-safe conditions
LED Illumination
UV Illumination, only for chamber lighting or visual documentation where suitable
IR Illumination, only if required for camera support
Camera
Exhaust
Environment Sensors
Offline / Manual / External Steps
Antibody concentration measurement
p H verification of conjugation buffer
Centrifugation and washing
Removal of unbound antibody
UV-Visible spectroscopy
DLS and zeta potential measurement
SDS-PAGE or protein assay confirmation, if required
Antigen-binding validation
Immunoassay performance testing
Long-term stability study
Methods: NSL-Compatible and Protoly-Managed Steps
Step 1: Chamber Preparation
Module / Step Type: Sterilization UV
Parameters: Suggested duration: 5 minutes
Description: Run a timed UV sterilization cycle before beginning the conjugate preparation workflow. This supports chamber preparation before handling nanoparticle and antibody solutions.
Step 2: Initial Environment Record
Module / Step Type: Environment Sensors
Parameters: Record ambient chamber condition
Description: Record the initial chamber environment before the run. This can be useful for comparing different conjugation batches prepared on different days.
Step 3: Chamber Illumination
Module / Step Type: LED Illumination
Parameters: White light illumination
Description: Turn on chamber illumination to support visual monitoring and camera documentation during reagent addition and incubation.
Step 4: Dispense Silver Nanoparticle Dispersion
Module / Step Type: Reservoir Dispense
Parameters: Reagent: pre-prepared Ag NP dispersion; suggested volume: 100-200 u L; channel: 1
Description: Dispense silver nanoparticle dispersion into the reaction vessel. The nanoparticle batch should be prepared and characterized separately before use in antibody conjugation.
Step 5: Dispense Conjugation Buffer
Module / Step Type: Reservoir Dispense
Parameters: Reagent: conjugation buffer; suggested volume: 50-150 u L; channel: 2
Description: Add suitable buffer or conditioning medium to maintain the desired conjugation environment. Accurate p H confirmation should be performed offline before loading the buffer.
Step 6: Gentle Pre-Mixing
Module / Step Type: Stirrer
Parameters: Mode: continuous; suggested RPM: 150-300; duration: 5-10 minutes
Description: Mix the nanoparticle dispersion and buffer gently. Low-speed stirring is preferred to avoid aggregation or mechanical stress.
Step 7: Dispense Antibody Solution
Module / Step Type: Reservoir Dispense
Parameters: Reagent: antibody solution; suggested volume: 10-50 u L; channel: 3
Description: Add antibody solution slowly into the conditioned Ag NP dispersion. Antibody concentration and compatibility should be decided based on the research design.
Step 8: Conjugation Incubation
Module / Step Type: Wait
Parameters: Suggested duration: 30-90 minutes
Description: Allow the Ag NP and antibody mixture to incubate under defined timing. This period supports antibody association with the nanoparticle surface.
Step 9: Gentle Mixing During Incubation
Module / Step Type: Stirrer
Parameters: Mode: intermittent or low-speed continuous; suggested RPM: 100-250
Description: Maintain gentle mixing if required. Excessive agitation should be avoided because it may destabilize nanoparticle-antibody conjugates.
Step 10: Optional Mild Thermal Conditioning
Module / Step Type: Heater
Parameters: Suggested temperature: room temperature to 30 C; condition: optional
Description: Use only mild temperature support if required. Avoid heating conditions that may denature antibodies or reduce binding activity.
Step 11: Dispense Blocking / Stabilizing Solution
Module / Step Type: Reservoir Dispense
Parameters: Reagent: blocking or stabilizer solution; suggested volume: 10-100 u L; channel: 4
Description: Add a blocking or stabilizing component to reduce non-specific surface interactions and improve conjugate dispersion stability.
Step 12: Stabilization Hold
Module / Step Type: Wait
Parameters: Suggested duration: 20-60 minutes
Description: Hold the mixture after stabilizer addition to allow surface blocking and preliminary conjugate stabilization.
Step 13: Final Gentle Mixing
Module / Step Type: Stirrer
Parameters: Mode: low-speed continuous; suggested RPM: 100-200; duration: 5-15 minutes
Description: Mix gently to distribute the stabilizer uniformly without causing foam or aggregation.
Step 14: Visual Documentation
Module / Step Type: LED Illumination and Camera
Parameters: Capture final appearance
Description: Document the final conjugate dispersion. Observe colour uniformity, visible aggregation, sedimentation, precipitation, and general dispersion stability.
Step 15: Manual Collection
Module / Step Type: Manual / offline step
Parameters: Transfer to labelled vial
Description: Collect the prepared conjugate into a clean labelled vial. Record batch ID, Ag NP batch, antibody type, buffer, incubation time, stabilizer, and visual observations.
Step 16: Offline Purification
Module / Step Type: External step
Parameters: Centrifugation, washing, dialysis, or filtration as suitable
Description: Remove unbound antibody if required. This is not an NSL module and should be documented as a downstream external process.
Step 17: External Validation
Module / Step Type: External step
Parameters: Analytical and immunoassay testing
Description: Evaluate conjugate quality using suitable external methods such as UV-Visible spectroscopy, DLS, zeta potential, protein assay, antigen binding, and immunoassay performance testing.
Methodology
The silver nanoparticle-antibody conjugate was prepared using a Protoly-managed and partially NSL-supported workflow. Before starting the preparation, the chamber was subjected to a timed UV sterilization cycle. The initial chamber condition was recorded using the environment sensor module, and LED illumination was activated to support visual monitoring.
A pre-prepared silver nanoparticle dispersion was dispensed into the reaction vessel using the reservoir dispensing module. A suitable conjugation buffer was added through a separate reservoir channel to condition the nanoparticle dispersion. The mixture was gently stirred to obtain a uniform starting dispersion before antibody addition. Buffer p H and antibody concentration were treated as pre-run or offline verification requirements.
The antibody solution was then added slowly into the conditioned Ag NP dispersion. The mixture was allowed to incubate for a defined period under gentle mixing or static conditions. This incubation stage was intended to support antibody association with the nanoparticle surface while avoiding excessive mechanical agitation. Mild temperature control was considered optional and limited to antibody-safe conditions only.
After the conjugation incubation, a blocking or stabilizing solution was added to support colloidal stability and reduce non-specific surface interactions. The mixture was held for stabilization and then gently mixed to ensure uniform distribution of the stabilizer. The final dispersion was visually documented using LED illumination and the camera module. Visible changes such as colour shift, aggregation, sedimentation, precipitation, or loss of dispersion uniformity were recorded as preliminary observations.
The prepared conjugate was manually collected into a clean labelled vial for downstream external processing. If required, unbound antibody was removed using offline purification such as centrifugation, washing, dialysis, or filtration. The conjugate was then suitable for external characterization and immunoassay validation. This workflow is intended for research-scale immunoassay probe preparation only and does not establish diagnostic or clinical performance.